Estrogen in Patients with Prostatic Cancer

@article{Henriksson1991EstrogenIP,
  title={Estrogen in Patients with Prostatic Cancer},
  author={P. Henriksson},
  journal={Drug Safety},
  year={1991},
  volume={6},
  pages={47-53}
}
SummaryEstrogen therapy of patients with prostatic carcinoma appears to be at least as effective in antitumour activity as surgical castration; the recent therapeutic alternative of gonadorelin (gonadotrophin-releasing hormone) analogues has not to date been shown to improve patient outcome.Oral estrogen therapy in these patients increases the incidence of arterial ischaemic events, thromboembolic events and congestive heart failure. A plausible mechanism behind the enhanced cardiovascular… Expand
View on Springer
ncbi.nlm.nih.gov
4 Citations

4 Citations

Citation Type

Citation Type

5 Oestrogens and atherosclerotic vascular disease—lipid factors
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.
Increased Mean Platelet Volume after Oestrogen Replacement Therapy
Effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate on some proteins related to haemostasis in prostatic carcinoma patients

References

SHOWING 1-10 OF 65 REFERENCES
The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma.
Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma.
Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen.
Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer.
Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate
Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma.
Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo
Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular system.
...
1
2
3
4
5
...